Dmitry Skvortsov

15PUBLICATIONS

44CO-AUTHORS

Metal organic frameworksCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|May 22, 2026

New redox-active Cu complexes with tridentate chelating ligands based on 2-thioimidazol-4-ones as potential antiproliferative agents.

|May 20, 2026

Spirocyclohexane-Chroman-4-one Derivatives as Selectively Cytotoxic Agents in Breast Cancer Models.

|Mar 24, 2026

Benzoxaborole-modified azithromycins inhibit translation without inducing <i>ermC</i> expression.

Inna A Volynkina, Michael O Bortyazh, Chih-Wei Chen

|Feb 11, 2026

Berberine C9-Derivatives Selective Cytotoxicity Depends on Balance Between Mitochondrial Damage and DNA Intercalation.

Anastasiia Yu Kolchanova, Konstantin G Lyamzaev, Nicolae Valutsa

|Jan 28, 2026

Scaffold Simplification Yields Potent Antibacterial Agents That Target Bacterial Topoisomerases.

Lyubov Khudiakova, Kristina Komarova, Maxim Zhuravlev

|Sep 19, 2025

Photoactivatable Cisplatin-Combretastatin-BODIPY Pt(IV) Prodrug for Dual-Action Light-Controlled Chemotherapy.

Daniil V Spector, Georgy Karetnikov, Anna Bubley

Pageof 3

Frequent Collaborators

Elena K Beloglazkina

Olga O Krasnovskaya

Roman Akasov

Georgy L Karetnikov

Alexander Vaneev

Alexander Erofeev

Dmitrii Lukianov

Alexey Lukin

Alexander G Martynov

Vasilii S Kolmogorov

Frequent Collaborators

Elena K Beloglazkina

Olga O Krasnovskaya

Roman Akasov

Georgy L Karetnikov